Osteosarcoma patients with PSMD14 overexpression had a lower disease-free survival and overall survival, as shown by the analysis of osteosarcoma data from the TARGET database using the GEPIA online software (Fig. 1I, J), which suggested that increased expression of PSMD14 predicted poor prognosis. This evidence concerns the gene PSMD14 and osteosarcoma.